Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001667699-16-000005
Filing Date
2016-05-02
Accepted
2016-05-02 15:12:23
Documents
1
Effectiveness Date
2016-05-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8794
  Complete submission text file 0001667699-16-000005.txt   9814
Mailing Address 727 LATHROP STREET LANTANA TX 76226
Business Address 727 LATHROP STREET LANTANA TX 76226 469-688-3174
Renibus Therapeutics, Inc. (Filer) CIK: 0001667699 (see all company filings)

EIN.: 810872431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-258033 | Film No.: 161611390